Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04441125
Other study ID # 76
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date September 20, 2020

Study information

Verified date November 2021
Source Saglik Bilimleri Universitesi
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Aim: This study has been planned as an observational study. The aim of this study is to determine the effect of labor induction with oxytocin on early postpartum hemorrhage, perineal integrity and breastfeeding. Materials and Methods: The sample consists of 88 healthy mother and infant pairs. The mothers in the case group will receive oxytocin induction before and after delivery. On the other hand, the mothers in the control group will not receive any oxytocin induction before delivery, and will receive oxytocin induction in the end of delivery. Data were collected by using the Personal Information Form, the LATCH Breastfeeding Diagnostic Scale, the Breastfeeding Self-Efficacy Scale, the follow-up bag for postpartum hemorrhage, and episiotomy healing assessment known as the REEDA Scale.


Description:

Oxytocin is applied to the women in the case group before the delivery. There is a procedure on the usage of oxytocin at the delivery room. In accordance with the relevant procedure, it is administered as an intravenous infusion by adding 5 units of oxytocin in 500 cc of physiological saline solution. The initial dosage is adjusted in order to allow for the flow of 4 drops per minute. Maximum 40 drops in total can be applied by increasing for 4 drops every 20 minutes. The dosage can be increased by considering the intensity and duration of contractions. The initial dosage of the oxytocin procedure applied to the women is the same for all women. As the total duration of delivery is different, there are differences between the dosages of oxytocin received. In accordance with the postpartum procedure at the delivery room, it is administered as an intravenous infusion to all women (primiparous, multiparous) by adding 20 units of oxytocin in 500 cc of physiological saline solution immediately after the delivery. The women in the control group do not receive any oxytocin induction before the delivery, and these women give birth spontaneously. After the delivery, the postpartum procedure applied for the control group is preferred. Episiotomy is applied routinely to the primiparous pregnant women at the gynecological examination table in order to enlarge the opening of the vagina during the delivery. Episiotomy is a surgical incision applied to the bulbo-cavernous muscle in the perineal region while the baby's head appears in order to protect the perineal tonus, prevent undesired repairs, and to provide an easy, quick and safe delivery by enlarging the vaginal opening. Medio-lateral episiotomy is applied routinely to all women. Immediately after the delivery, the baby's umbilical cord is clamped and cut. The postpartum hemorrhage bag is placed under the mother's perineal region immediately after the umbilical cord is cut, and it is waited for separation of the placenta. The duration for separation of the placenta is 30 minutes in maximum. After separation of the placenta, episiotomy repair is made. The loss of blood in the postpartum hemorrhage bag is recorded after the episiotomy repair. Before the woman is taken to her bed, necessary pads are provided, postpartum hemorrhage is followed-up, and the pads are weighed in the 24th postpartum hour. The perineal region is evaluated by the REEDA scale in the postpartum 12th hour and the The LATCH, the Breastfeeding Assessment, and the BSES are applied in the postpartum 24th hour and the first week.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date September 20, 2020
Est. primary completion date August 15, 2020
Accepts healthy volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Women aged 18-35 years, - having a single pregnancy, - literate, - between 37-42 gestational week, - hemoglobin level of 10 g and above, - without chronic, mental and psychological disease Infants; - without congenital anomalies, - with a first Apgar score of 8 and above, - birth weight between 2500 - 4000 g - no obstruction to oral feeding Exclusion Criteria: - multiparity, - any risky condition development in the mother and baby during or after birth

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Zeynep Kamil Women's and Children's Diseases Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Saglik Bilimleri Universitesi

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The REEDA (Redness, Oedema, Ecchymosis, Discharge and Approximation) Assessment is made by giving 0, 1, 2 and 3 scores to each title in the scale, and 0 is the lowest score and 15 is the highest score. 0 is the normal value for total score. In the scale, an increase in score indicates that there is pathology, and a decrease in score indicates that there is a recovery.
The REEDA score is evaluated in the 12th hour after delivery.
12th hour
Primary The Breastfeeding Self-Efficacy Scale(BSES) This form is a five-point Likert-type scale, and it is scored as follows: "1=not at all confident", "2=not very confident", "3=sometimes confident", "4=confident?, "5=very confident?.
The Breastfeeding Self-Efficacy Scale consists of 14 items.
The lowest score which can be achieved from the scale is 14, and the highest score is 70.
Achieving a high score indicates that the mothers have a high breastfeeding self-efficacy.
The Breastfeeding Self-Efficacy is evaluated in the 24th hour after delivery.
24th hour
Primary L (LATCH on breast) A (Audible Swallowing) T (Type of Nipple) C (Comfort of Breast/Nipple) H (Hold/Positioni The LATCH: It consists of five evaluation criteria.
Each item is evaluated between the score range of "0 - 2?. In the scale, the highest score which can be achieved is 10, and the lowest score is 0. As the score achieved from this scale increases, the success in breastfeeding increases.
The LATCH score is evaluated in the 24th hour after delivery.
24th hour
Primary The Follow-up Bag for Postpartum Hemorrhage(postpartum blood bag +pad weigth ) The postpartum hemorrhage bag has been calibrated in order to help for the follow-up of vaginal hemorrhage and fluid, and has been designed as filtration-specific. The bag is transparent colored, and the amount within the bag is recorded as milliliter.The postpartum hemorrhage bag is placed under the mother's perineal region after the delivery in order to measure the postpartum hemorrhage, and the amount of hemorrhage is recorded when the mother leaves the gynecological table. Then, the hemorrhage follow-up is made through a pad when the mother is taken to the bed. All pads are sterile and same in size. In the 24th postpartum hour, the pads used by the researcher are weighed and recorded. 24th hour
Secondary The REEDA (Redness, Oedema, Ecchymosis, Discharge and Approximation) Assessment is made by giving 0, 1, 2 and 3 scores to each title in the scale, and 0 is the lowest score and 15 is the highest score. 0 is the normal value for total score. In the scale, an increase in score indicates that there is pathology, and a decrease in score indicates that there is a recovery.
The REEDA score is evaluated in the 24th hour after delivery.
24th hour
Secondary The Breastfeeding Self-Efficacy Scale(BSES) This form is a five-point Likert-type scale, and it is scored as follows: "1=not at all confident", "2=not very confident", "3=sometimes confident", "4=confident?, "5=very confident?.
The Breastfeeding Self-Efficacy Scale consists of 14 items.
The lowest score which can be achieved from the scale is 14, and the highest score is 70.
Achieving a high score indicates that the mothers have a high breastfeeding self-efficacy.
The Breastfeeding Self-Efficacy is evaluated in the first week after delivery.
The first week
Secondary L (LATCH on breast) A (Audible Swallowing) T (Type of Nipple) C (Comfort of Breast/Nipple) H (Hold/Positioni The LATCH: It consists of five evaluation criteria.
Each item is evaluated between the score range of "0 - 2?. In the scale, the highest score which can be achieved is 10, and the lowest score is 0. As the score achieved from this scale increases, the success in breastfeeding increases.
The LATCH score is evaluated in the first week after delivery.
The first week
See also
  Status Clinical Trial Phase
Completed NCT02566356 - Adult Study Oxytocin - fMRI Early Phase 1
Completed NCT04330677 - Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin Phase 1
Completed NCT05827731 - Cervical Double Balloon Combined With Oxytocin N/A
Completed NCT02567032 - Adult Study Oxytocin - Behavioral Early Phase 1
Recruiting NCT04760496 - Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour Phase 4
Completed NCT03096249 - The Influence of Oxytocin on Socio-communicative Sensitivity Phase 1/Phase 2
Recruiting NCT05079841 - The Stimulation To Induce Mothers Study Phase 4
Completed NCT05059028 - Effect of Oxytocin Massage and Music on Breastfeeding N/A
Enrolling by invitation NCT06403982 - The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia N/A
Completed NCT03140709 - Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids N/A
Recruiting NCT04109339 - Effects of Oxytocin on Hemodynamics in Patients Undergoing Laparoscopic Myomectomy N/A
Completed NCT01891201 - Intrapartum Oxytocin Administration Affects Primitive Neonatal Reflexes N/A
Completed NCT05357521 - Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder
Completed NCT03140488 - Oxytocin Dosage to Decrease Induction Duration Phase 4
Completed NCT05823441 - Effect of Oxytocin Nasal Inhalation on Empathy Analgesia Phase 4
Not yet recruiting NCT06010368 - Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section Phase 3
Withdrawn NCT05608070 - IV Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy Phase 4
Recruiting NCT04551482 - Oxytocin for Weight Loss in Adolescents Phase 2
Completed NCT03272321 - Influence of Oxytocin on Neurophysiological Responses to Live Faces Phase 1/Phase 2
Completed NCT03255148 - Influence of Oxytocin on Resting State Neurophysiological Measures Phase 1